Hammersmith Medicines Research Ltd

Hammersmith Medicines Research Ltd (HMR) is a leading Contract Research Organisation (CRO) specializing in providing comprehensive services for Phase 1 and early Phase 2 studies. With spacious premises spanning 5995 m² and equipped with 145 beds, a dedicated sleep unit for polysomnography, advanced laboratories, a state-of-the-art pharmacy (including an aseptic unit and radiopharmacy), and comfortable volunteer facilities, Hammersmith Medicines Research Ltd is well-equipped to handle a wide range of clinical trials.

Located in London at Cumberland Avenue, NW10 7EW, GB, Hammersmith Medicines Research Ltd boasts a team of over 250 highly skilled professionals, including physicians, nurses, and graduates with advanced degrees. Since 1993, HMR has successfully completed over 850 studies, establishing itself as one of the largest and most reputable early-phase CROs in Europe. Hammersmith Medicines Research Ltd is committed to advancing medical science through rigorous research and unwavering dedication to patient safety.

Hammersmith Medicines Research Ltd's expertise encompasses a wide array of specialized studies, including bridging studies, metabolic studies (both 'cold' and radiolabelled), sleep studies, first administration to man, pharmacokinetic studies, pharmacodynamic studies, safety & tolerability testing, and drug interaction assessments. We invite the management of Hammersmith Medicines Research Ltd to create a customized and exclusive company showcase and product listing on our platform to further enhance their visibility and reach.